Intelligent Bio Solutions Inc.
INBS
$4.00
-$0.02-0.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.58% | -4.31% | -4.06% | -2.31% | 20.16% |
| Total Depreciation and Amortization | -3.07% | 0.45% | 0.05% | 9.10% | 5.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.12% | 398.37% | 438.65% | 246.98% | -88.82% |
| Change in Net Operating Assets | 95.73% | 23.11% | -2.71% | -183.26% | -168.42% |
| Cash from Operations | 7.16% | 4.79% | -1.11% | -44.36% | -38.70% |
| Capital Expenditure | -108.24% | -36.50% | -4.70% | -252.31% | -202.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -85.14% | -36.50% | -4.70% | 19.20% | -168.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -41.44% | -44.58% | -68.56% | -72.65% | 256.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -96.52% | -- | -- | 138.01% | 141.78% |
| Cash from Financing | -28.76% | -44.44% | -68.42% | -72.60% | 106.28% |
| Foreign Exchange rate Adjustments | 187.37% | -105.26% | 4,633.33% | 128.77% | -932.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -233.71% | -161.25% | -210.85% | -192.60% | 162.66% |